Amerant (AMTB) Q2 2026 earnings review
Clean Execution on the Turnaround Strategy
Amerant is successfully executing its 'stabilize, optimize, and grow' playbook. Following a painful 'kitchen sink' restructuring in Q4 2025, the bank has posted two consecutive quarters of sequential earnings growth. Q2 Net Income rose 17% QoQ to $21.0 million, driven by a massive $552 million surge in core deposits and a meaningful reduction in credit provision costs. Asset quality—the primary concern over the last year—is finally reversing course, with classified loans dropping nearly 15%. Management's path to a 1% ROA by year-end looks increasingly credible as low-cost international deposits re-fund the balance sheet.
🐂 Bull Case
Core deposits jumped 9.4% sequentially, heavily fueled by low-cost international inflows (notably from Venezuela). This drove the cost of total deposits down 10 bps to 2.21%, providing a rare funding tailwind in a higher-for-longer rate environment.
Proactive loan sales and aggressive risk management are working. Classified loans fell $47.2M (14.7%) and Special Mention loans plummeted 25.9%. Net charge-offs are effectively zero at 0.08%.
🐻 Bear Case
Despite falling deposit costs, Net Interest Margin (NIM) still ticked down slightly to 3.52% from 3.55%, dragged lower by compressing loan yields as the bank swaps out higher-risk, higher-yield loans for safer assets.
While Non-Performing Loans (NPLs) ticked down to $171.1M, they still represent 2.49% of total loans—more than double the 1.15% level reported in Q2 2025. The baseline risk remains elevated.
⚖️ Verdict: 🟢
Bullish. The bank is doing exactly what it promised: stabilizing credit, cutting costs, and driving low-cost core deposit growth. If they hit their Q4 targets, the stock's valuation should re-rate.
Key Themes
International Deposit Surge Lowers Funding Costs
Amerant's unique positioning as a safe haven for international capital—specifically capturing wealth from Venezuela's economic reactivation—is paying massive dividends. Core deposits grew by $552.6 million (9.4%) sequentially. This influx of low-cost capital drove the overall cost of deposits down 10 bps to 2.21%, defying broader industry trends of funding cost pressure.
Aggressive Portfolio De-risking Yielding Results
Management's ruthless approach to shedding bad debt is cleaning up the balance sheet. Classified loans dropped 14.7% sequentially to $273.1M, and Special Mention loans plummeted 25.9% to $109.8M, driven heavily by targeted loan sales and payoffs. Net charge-offs (NCOs) fell to a negligible 0.08%, indicating that the worst of the credit bleeding may be over.
Loan Yields Dragging NIM Lower
In a direct contradiction to the positive narrative surrounding falling deposit costs, Net Interest Margin (NIM) still decelerated slightly from 3.55% to 3.52%. Why? Because the average yield on loans dropped 16 bps sequentially to 6.22%. As Amerant originates newer, safer loans, it is sacrificing yield, offsetting the benefits of its cheap deposit inflows.
Operating Leverage and the Path to 1% ROA
Amerant is leveraging its recent FIS core system conversion to clean data, implement AI-driven efficiencies, and strip out legacy vendor costs. Noninterest expense rose slightly QoQ to $68.9M but is guided to drop to $66-$67M by Q4. This structural expense decline, paired with expanding net interest income, is the primary driver behind management's explicit target of a 1.00% ROA by year-end.
NPL Baseline Remains Sticky
While the direction is positive, the absolute volume of problem assets remains a hangover from 2025. Non-Performing Loans (NPLs) sit at $171.1M. This is 2.49% of gross loans—down from 2.61% last quarter, but still aggressively higher than the 1.15% printed in Q2 2025. The bank must continue to execute flawless workouts to avoid future provisioning shocks.
Crossing the $10 Billion Regulatory Threshold
Total assets ended the quarter at $10.29B. Management previously shrank the balance sheet intentionally in late 2025 to avoid the heightened regulatory scrutiny and Durbin Amendment fee caps associated with crossing the $10B mark. Now that they have decisively crossed it, investors must monitor for sudden jumps in compliance and infrastructure expenses.
Other KPIs
Accelerating. Up 3.6% from $30.7M in Q1. This metric proves that the core operating engine of the bank is growing stronger, stripping out the volatility of credit provisioning and taxes. This is the highest PPNR since Q3 2025.
Amerant aggressively bought back 690,000 shares at a weighted average price of $23.29, roughly equal to its Tangible Book Value ($22.78). Combined with the $0.09 quarterly dividend, management is actively returning excess capital while the stock trades at perceived discounts.
CRE remains the largest segment risk, representing 33.7% of total loans. However, the portfolio is well-diversified geographically (Florida 77%, NY 5%, TX 6%) and by property type, with a conservative weighted average LTV of roughly 60% across its office and retail segments.
Guidance
Accelerating. Implies roughly 6.3% growth from the current $6.86B level over the next two quarters. This confirms management's view that they have finished intentionally shrinking the portfolio to remove bad credits and are pivoting back to organic origination.
Accelerating. Implies roughly 8.9% growth from the current $8.35B level over the next two quarters. This is an aggressive target that relies heavily on continued momentum in their international deposit-gathering pipeline.
Stable. Suggests the current slight compression (down to 3.52% this quarter) will hit a floor as the rotation into lower-yielding, safer loans balances out against the influx of sub-1% international core deposits.
Decelerating. A targeted drop from the current $68.9M run-rate. Hitting this number is the linchpin requirement for the bank to achieve its guided ~60% efficiency ratio and 1.00% ROA.
Key Questions
Sustainability of Venezuelan Inflows
Core deposit growth was heavily reliant on international inflows. If geopolitical dynamics shift or sanctions are reapplied, what is the contingency plan for replacing this critical, low-cost funding?
Loan Yield Compression
Your deposit costs are dropping beautifully, but loan yields fell 16 bps sequentially, compressing NIM. Are you having to underprice competitors to win 'safer' C&I and CRE deals?
NPL Resolution Pace
With $171M remaining in Non-Performing Loans, are you planning further bulk sales at a discount to clear the decks before year-end, or will you work these out organically over the next 12-18 months?
Regulatory Costs of $10B Threshold
Now that you have decisively crossed the $10 billion asset mark ($10.29B this quarter), what specific incremental compliance costs and Durbin Amendment fee hits are baked into your 2027 run-rate?